Advertisement

Millions Depend on Our Support for Insulin Price Capping

Published:December 06, 2022DOI:https://doi.org/10.1016/j.nurpra.2022.11.009

      Highlights

      • Millions in the United States struggle to afford their prescribed insulin.
      • Recent legislation provides insulin price capping only for Medicare recipients
      • No current legislation provides relief for those with private insurance or who are uninsured.
      • Nurse practitioners are in a unique position to help shape public health policy.
      • Nurse practitioners should feel empowered to contact their representatives and advocate for their patients by supporting insulin price capping.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Biography

      Lindsay Appleton, MSN, AGACNP-BC, RN-BC, CEN, is a nurse practitioner practicing in Charlotte, NC. She can be contacted at [email protected]